Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.33 |
| ▸ | CA6 | P23280 | 3/20 | 0.33 |
| ▸ | CA7 | P43166 | 3/20 | 0.33 |
| ▸ | CA9 | Q16790 | 3/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA3 | P07451 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | CA5A | P35218 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15489990 | 1.00 | CA12 (0.33) | CA12CA6CA7CA9CA14 | |
| SCHEMBL15489980 | 0.94 | CA12 (0.35) | CA12CA6CA7CA9CA14 | |
| SCHEMBL12658744 | 0.94 | CA12 (0.35) | CA12CA6CA7CA9CA14 | |
| SCHEMBL10108305 | 0.90 | CA12 (0.38) | CA12CA6CA7CA9CA14 | |
| SCHEMBL13038582 | 0.89 | CA12 (0.39) | CA12CA6CA7CA9CA14 | |
| SCHEMBL19286519 | 0.87 | CA12 (0.38) | CA12CA6CA7CA9CA14 | |
| SCHEMBL4941508 | 0.87 | CA12 (0.44) | CA12CA6CA7CA9CA14 | |
| SCHEMBL26324758 | 0.85 | — | — | |
| SCHEMBL15290372 | 0.85 | CA12 (0.31) | CA12CA6CA7CA9CA14 | |
| SCHEMBL15489981 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9439842-B2 | Use of acid in the manufacture of organopolysiloxane | DOW CORNING TORAY CO. LTD. (JP) | 2016-09-13 | — | — | US | disclosed |
| US-20140356309-A1 | Use Of Acid In The Manufacture Of Organopolysiloxane | DOW TORAY CO., LTD. (JP) | 2014-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140356309-A1 | Use Of Acid In The Manufacture Of Organopolysiloxane | HAAO, HAO2, DAO | CA12 397/4885CA6 194/4885CA7 76/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.